PP2A holoenzymes negatively and positively regulate cell cycle progression by dephosphorylating pocket proteins and multiple CDK substrates

Gene

Volumn 499, Issue 1, 2012, Pages 1-7

  Kurimchak, Alison ^a   Graña, Xavier ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

B55alpha; E2F; P107; P130; PRB; Retinoblastoma

Indexed keywords

BONE MORPHOGENETIC PROTEIN; CELL CYCLE PROTEIN 6; CELL EXTRACT; CYCLIN DEPENDENT KINASE; FIBROBLAST GROWTH FACTOR 1; HOLOENZYME; HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN SERINE THREONINE KINASE; RAF PROTEIN; RETINOIC ACID; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; WNT PROTEIN;

CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL MATURATION; CHROMOSOME 9; CRYSTAL STRUCTURE; ENZYME ACTIVITY; ENZYME INACTIVATION; HUMAN; IN VITRO STUDY; MAMMAL CELL; MITOSIS; NONHUMAN; OOCYTE; OVARY CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REVIEW; RNA INTERFERENCE; SIGNAL TRANSDUCTION; ULTRAVIOLET IRRADIATION; UPREGULATION; XENOPUS;

ANIMALS; CELL CYCLE; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASES; HOLOENZYMES; HUMANS; MODELS, BIOLOGICAL; PHOSPHORYLATION; PROTEIN PHOSPHATASE 2; SUBSTRATE SPECIFICITY;

EID: 84859774713     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.02.015     Document Type: Review

References (63)

1. Adams D.G., Coffee R.L., Zhang H., Pelech S., Strack S., Wadzinski B.E. Positive regulation of Raf1-MEK1/2-ERK1/2 signaling by protein serine/threonine phosphatase 2A holoenzymes. J. Biol. Chem. 2005, 280:42644-42654.
2. 2+-dependent dephosphorylation of DARPP-32 by protein phosphatase 2A. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:9876-9881.
3. Bengtsson L., Schwappacher R., Roth M., Boergermann J.H., Hassel S., Knaus P. PP2A regulates BMP signalling by interacting with BMP receptor complexes and by dephosphorylating both the C-terminus and the linker region of Smad1. J. Cell Sci. 2009, 122:1248-1257.
4. Bhattacharya S., Garriga J., Calbo J., Yong T., Haines D.S., Graña X. SKP2 associates with p130 and accelerates p130 ubiquitylation and degradation in human cells. Oncogene 2003, 22:2443-2451.
5. Calbó J., et al. G1 cyclin/CDK coordinated phosphorylation of endogenous pocket proteins differentially regulates their interactions with E2F4 and E2F1 and gene expression. J. Biol. Chem. 2002, 277:50263-50274.
6. Castilho P.V., Williams B.C., Mochida S., Zhao Y., Goldberg M.L. The M phase kinase Greatwall (Gwl) promotes inactivation of PP2A/B55delta, a phosphatase directed against CDK phosphosites. Mol. Biol. Cell 2009, 20:4777-4789.
7. Chen C.R., Kang Y., Siegel P.M., Massague J. E2F4/5 and p107 as Smad cofactors linking the TGFbeta receptor to c-myc repression. Cell 2002, 110:19-32.
8. Cho U.S., Xu W. Crystal structure of a protein phosphatase 2A heterotrimeric holoenzyme. Nature 2007, 445:53-57.
9. Cicchillitti L., Fasanaro P., Biglioli P., Capogrossi M.C., Martelli F. Oxidative stress induces PP2A-dependent de-phosphorylation of the pocket proteins pRb, p107 and p130. J. Biol. Chem. 2003, 278:19509-19517.
10. Cobrinik D., et al. Shared role of the pRb-related p130 and p107 proteins in limb development. Genes Dev. 1996, 10:1633-1644.
11. Creyghton M.P., et al. PR72, a novel regulator of Wnt signaling required for Naked cuticle function. Genes Dev. 2005, 19:376-386.
12. Creyghton M.P., Roel G., Eichhorn P.J., Vredeveld L.C., Destree O., Bernards R. PR130 is a modulator of the Wnt-signaling cascade that counters repression of the antagonist Naked cuticle. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:5397-5402.
13. Dailey L., Laplantine E., Priore R., Basilico C. A network of transcriptional and signaling events is activated by FGF to induce chondrocyte growth arrest and differentiation. J. Cell Biol. 2003, 161:1053-1066.
14. Davis A.J., Yan Z., Martinez B., Mumby M.C. Protein phosphatase 2A is targeted to cell division control protein 6 by a calcium-binding regulatory subunit. J. Biol. Chem. 2008, 283:16104-16114.
15. De Wulf P., Montani F., Visintin R. Protein phosphatases take the mitotic stage. Curr. Opin. Cell Biol. 2009, 21:806-815.
16. Dunaief J.L., et al. Protein phosphatase 1 binds strongly to the retinoblastoma protein but not to p107 or p130 in vitro and in vivo. Curr. Eye Res. 2002, 24:392-396.
17. Durfee T., et al. The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit. Genes Dev. 1993, 7:555-569.
18. Eichhorn P.J., Creyghton M.P., Bernards R. Protein phosphatase 2A regulatory subunits and cancer. Biochim. Biophys. Acta 2008, 1795:1-15.
19. Eichhorn P.J., Creyghton M.P., Wilhelmsen K., van Dam H., Bernards R. A RNA interference screen identifies the protein phosphatase 2A subunit PR55gamma as a stress-sensitive inhibitor of c-SRC. PLoS Genet. 2007, 3:e218.
20. Garriga J., et al. A Dynamic Equilibrium Between CDKs and PP2A Modulates Phosphorylation of pRB, p107 and p130. Cell Cycle 2004, 3.
21. Gharbi-Ayachi A., et al. The substrate of Greatwall kinase, Arpp 19, controls mitosis by inhibiting protein phosphatase 2A. Science 2010, 330:1673-1677.
22. Graña X. Downregulation of the phosphatase nuclear targeting subunit (PNUTS) triggers pRB dephosphorylation and apoptosis in pRB positive tumor cell lines. Cancer Biol. Ther. 2008, 7:842-844.
23. Griswold-Prenner I., Kamibayashi C., Maruoka E.M., Mumby M.C., Derynck R. Physical and functional interactions between type I transforming growth factor beta receptors and Balpha, a WD-40 repeat subunit of phosphatase 2A. Mol. Cell. Biol. 1998, 18:6595-6604.
24. Hendrix P., et al. Structure and expression of a 72-kDa regulatory subunit of protein phosphatase 2A. Evidence for different size forms produced by alternative splicing. J. Biol. Chem. 1993, 268:15267-15276.
25. Hirschi A., Cecchini M., Steinhardt R.C., Schamber M.R., Dick F.A., Rubin S.M. An overlapping kinase and phosphatase docking site regulates activity of the retinoblastoma protein. Nat. Struct. Mol. Biol. 2010, 17:1051-1057.
26. Iwashita J., Shima H., Nagao M., Sagata N. cDNA cloning of a novel B subunit of Xenopus protein phosphatase 2A and its biological activity in oocytes. Biochem. Biophys. Res. Commun. 1997, 232:218-222.
27. 2+-binding EF-hand motifs in the B″/PR72 subunit of protein phosphatase 2A. J. Biol. Chem. 2003, 278:10697-10706.
28. Jayadeva G., et al. B55alpha PP2A holoenzymes modulate the phosphorylation status of the retinoblastoma-related protein p107 and its activation. J. Biol. Chem. 2010, 285:29863-29873.
29. Kolupaeva V., Laplantine E., Basilico C. PP2A-mediated dephosphorylation of p107 plays a critical role in chondrocyte cell cycle arrest by FGF. PLoS One 2008, 3:e3447.
30. Kono Y., et al. MCM3-binding GANP DNA-primase is associated with a novel phosphatase component G5PR. Genes Cells 2002, 7:821-834.
31. Lacy S., Whyte P. Identification of a p130 domain mediating interactions with cyclin A/cdk 2 and cyclin E/cdk 2 complexes. Oncogene 1997, 14:2395-2406.
32. Laplantine E., Rossi F., Sahni M., Basilico C., Cobrinik D. FGF signaling targets the pRb-related p107 and p130 proteins to induce chondrocyte growth arrest. J. Cell Biol. 2002, 158:741-750.
33. Lee T.H., Turck C., Kirschner M.W. Inhibition of cdc2 activation by INH/PP2A. Mol. Biol. Cell 1994, 5:323-338.
34. Ludlow J.W., Glendening C.L., Livingston D.M., DeCarprio J.A. Specific enzymatic dephosphorylation of the retinoblastoma protein. Mol. Cell. Biol. 1993, 13:367-372.
35. Magenta A., Fasanaro P., Romani S., Di Stefano V., Capogrossi M.C., Martelli F. Protein phosphatase 2A subunit PR70 interacts with pRb and mediates its dephosphorylation. Mol. Cell. Biol. 2008, 28:873-882.
36. Manchado E., et al. Targeting mitotic exit leads to tumor regression in vivo: modulation by Cdk1, Mastl, and the PP2A/B55alpha, delta phosphatase. Cancer Cell 2010, 18:641-654.
37. Mochida S., Ikeo S., Gannon J., Hunt T. Regulated activity of PP2A-B55 delta is crucial for controlling entry into and exit from mitosis in Xenopus egg extracts. EMBO J. 2009, 28:2777-2785.
38. Mochida S., Maslen S.L., Skehel M., Hunt T. Greatwall phosphorylates an inhibitor of protein phosphatase 2A that is essential for mitosis. Science 2010, 330:1670-1673.
39. Moreno C.S., et al. WD40 repeat proteins striatin and S/G(2) nuclear autoantigen are members of a novel family of calmodulin-binding proteins that associate with protein phosphatase 2A. J. Biol. Chem. 2000, 275:5257-5263.
40. Nelson D.A., Krucher N.A., Ludlow J.W. High molecular weight protein phosphatase type 1 dephosphorylates the retinoblastoma protein. J. Biol. Chem. 1997, 272:4528-4535.
41. Nelson D.A., Ludlow J.W. Characterization of the mitotic phase pRb-directed protein phosphatase activity. Oncogene 1997, 14:2407-2415.
42. Purev E., Giordano A., Soprano D.R., Soprano K.J. Interaction of PP2A catalytic subunit with Rb2/p130 is required for all-trans retinoic acid suppression of ovarian carcinoma cell growth. J. Cell. Physiol. 2006, 206:495-502.
43. Purev E., Soprano D.R., Soprano K.J. PP2A interaction with Rb2/p130 mediates translocation of Rb2/p130 into the nucleus in all-trans retinoic acid-treated ovarian carcinoma cells. J. Cell. Physiol. 2011, 226:1027-1034.
44. Schmitz M.H., et al. Live-cell imaging RNAi screen identifies PP2A-B55alpha and importin-beta1 as key mitotic exit regulators in human cells. Nat. Cell Biol. 2009, 12:886-893.
45. Shi Y. Serine/threonine phosphatases: mechanism through structure. Cell 2009, 139:468-484.
46. Sotillo E., Graña X. Escape from cellular quiescence. Cell Cycle Deregulation in Cancer, Contemporary Cancer Research 2010, 3-22. Springer Publishing.
47. Sullivan M., Morgan D.O. Finishing mitosis, one step at a time. Nat. Rev. Mol. Cell Biol. 2007, 8:894-903.
48. Swanhart L.M., Sanders A.N., Duronio R.J. Normal regulation of Rbf1/E2f1 target genes in Drosophila type 1 protein phosphatase mutants. Dev. Dyn. 2007, 236:2567-2577.
49. Tedesco D., Lukas J., Reed S.I. The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCF(Skp2). Genes Dev. 2002, 16:2946-2957.
50. Ubersax J.A., et al. Targets of the cyclin-dependent kinase Cdk1. Nature 2003, 425:859-864.
51. Vigneron S., Brioudes E., Burgess A., Labbe J.C., Lorca T., Castro A. Greatwall maintains mitosis through regulation of PP2A. EMBO J. 2009, 28:2786-2793.
52. Virshup D.M., Shenolikar S. From promiscuity to precision: protein phosphatases get a makeover. Mol. Cell 2009, 33:537-545.
53. Voorhoeve P.M., Hijmans E.M., Bernards R. Functional interaction between a novel protein phosphatase 2A regulatory subunit, PR59, and the retinoblastoma-related p107 protein. Oncogene 1999, 18:515-524.
54. Voorhoeve P.M., Watson R.J., Farlie P.G., Bernards R., Lam E.W. Rapid dephosphorylation of p107 following UV irradiation. Oncogene 1999, 18:679-688.
55. Wirt S.E., Sage J. p107 in the public eye: an Rb understudy and more. Cell Div. 2010, 5:9.
56. Woo M.S., Sanchez I., Dynlacht B.D. p130 and p107 use a conserved domain to inhibit cellular cyclin-dependent kinase activity. Mol. Cell. Biol. 1997, 17:3566-3579.
57. Wurzenberger C., Gerlich D.W. Phosphatases: providing safe passage through mitotic exit. Nat. Rev. Mol. Cell Biol. 2011, 12:469-482.
58. Xu Y., Chen Y., Zhang P., Jeffrey P.D., Shi Y. Structure of a protein phosphatase 2A holoenzyme: insights into B55-mediated Tau dephosphorylation. Mol. Cell 2008, 31:873-885.
59. Xu Y., et al. Structure of the protein phosphatase 2A holoenzyme. Cell 2006, 127:1239-1251.
60. Yan Z., Fedorov S.A., Mumby M.C., Williams R.S. PR48, a novel regulatory subunit of protein phosphatase 2A, interacts with Cdc6 and modulates DNA replication in human cells. Mol. Cell. Biol. 2000, 20:1021-1029.
61. Zhang W., et al. PR55 alpha, a regulatory subunit of PP2A, specifically regulates PP2A-mediated beta-catenin dephosphorylation. J. Biol. Chem. 2009, 284:22649-22656.
62. Zhu L., Enders G., Lees J.A., Beijersbergen R.L., Bernards R., Harlow E. The pRB-related protein p107 contains two growth suppression domains: independent interactions with E2F and cyclin/cdk complexes. EMBO J. 1995, 14:1904-1913.
63. Zhu L., Harlow E., Dynlacht B.D. p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F. Genes Dev. 1995, 9:1740-1752.